| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Kidswell Bio Corporation
TSE:4584
Kidswell Bio Corporation
Cash & Cash Equivalents
Kidswell Bio Corporation
Cash & Cash Equivalents Peer Comparison
2160
4587
4974
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Kidswell Bio Corporation
TSE:4584
|
Cash & Cash Equivalents
¥2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
GNI Group Ltd
TSE:2160
|
Cash & Cash Equivalents
¥20.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
34%
|
CAGR 10-Years
15%
|
|
|
PeptiDream Inc
TSE:4587
|
Cash & Cash Equivalents
¥27.3B
|
CAGR 3-Years
33%
|
CAGR 5-Years
35%
|
CAGR 10-Years
24%
|
|
|
Takara Bio Inc
TSE:4974
|
Cash & Cash Equivalents
¥35.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
5%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash & Cash Equivalents
¥4.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
13%
|
|
S
|
StemRIM Inc
TSE:4599
|
Cash & Cash Equivalents
¥10.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
See Also
What is Kidswell Bio Corporation's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.2B
JPY
Based on the financial report for Mar 31, 2024, Kidswell Bio Corporation's Cash & Cash Equivalents amounts to 2.2B JPY.
What is Kidswell Bio Corporation's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
3%
Over the last year, the Cash & Cash Equivalents growth was 109%. The average annual Cash & Cash Equivalents growth rates for Kidswell Bio Corporation have been 15% over the past three years , 2% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
